STOCK TITAN

Johnson & Johnson to Participate in the Bernstein 38th Annual Strategic Decisions Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

NEW BRUNSWICK, N.J., May 2, 2022 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Bernstein 38th Annual Strategic Decisions Conference on Wednesday, June 1st, at the New York Hilton Midtown in New York. Joaquin Duato, Chief Executive Officer will represent the Company in a session scheduled at 10:00 a.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48-hrs after the live webcast.

(PRNewsfoto/Johnson & Johnson)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-the-bernstein-38th-annual-strategic-decisions-conference-301537487.html

SOURCE Johnson & Johnson

Johnson & Johnson

NYSE:JNJ

JNJ Rankings

JNJ Latest News

JNJ Stock Data

359.25B
2.40B
0.09%
71.24%
0.66%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
NEW BRUNSWICK

About JNJ

Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods.